RZLT Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own RZLT shares is 57, representing 64.24% of the company's common stock.

FIRST MANHATTAN CO. LLC., in the last quarter, reduced its stake in RZLT by -100% restricting it's holding to 0 shares of worth nearly -. SILVERARC CAPITAL MANAGEMENT, LLC also lessened -3.25% of the RZLT shares from its portfolio, reducing its holding to 151.99 thousand shares of worth $387.56K. STONEPINE CAPITAL MANAGEMENT, LLC also shunned RZLT shares holding by -95.61% last quarter which brought its holding to 121.48 thousand shares worth $309.77K.

As per its latest 13F filing, UBS OCONNOR LLC increased its stake in RZLT by 4.16% in the last quarter. The institutional holder raised its holding to 626.26 thousand shares having worth more than $1.60M. CITADEL ADVISORS LLC also added 14.97% more shares of RZLT to its portfolio, raising its holding to 398.42 thousand shares of worth $1.02M. BLACKROCK INC. also increased its RZLT shares holding by 35.4% which brought its holding to 354.92 thousand shares worth $905.04K.

The insider with the most stakes in RZLT is Genexine Inc. , 10 percent owner at the company. Additionally, RZLT stock is highly held by HANDOK, INC. and CFO Evans Daron among others.

Company executives, directors, and other insiders own 13.74% percent of Rezolute, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which RZLT insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 4 transaction(s) during the past 6-months in which Rezolute, Inc. insiders have bought stock, totalling 33808 shares

Around 465.47K Rezolute, Inc. shares are held by insiders, which represents about 13.74% of RZLT stock.

RZLT 10 percent owner, Genexine Inc. holds the largest portfolio of the company's shares. RZLT shares owned by Genexine total nearly 91.3 million.

FIRST MANHATTAN CO. LLC. is the largest institutional owner in RZLT which holds 0 shares worth - or 0% of the total RZLT shares outstanding followed by ADAGE CAPITAL PARTNERS GP, L.L.C. with ownership of 631.69 thousand shares representing 1.23% of the RZLT ownership. UBS OCONNOR LLC is the third largest stakeholder with 626.26 thousand shares or 1.22% of the ownership worth more than $1.60M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the RZLT is concerned, it is a stock which is optionable.

Number of RZLT shares short is 1.15M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 57.94M shares of RZLT are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, RZLT has 42.03M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for RZLT is 3.16.